Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT00142870 Completed - Clinical trials for Substance-Related Disorders

Effectiveness of Bupropion in Treating Marijuana Dependent Individuals

Start date: March 2005
Phase: Phase 2
Study type: Interventional

A definable and significant withdrawal syndrome occurs upon cessation of chronic, heavy marijuana use. Bupropion (Zyban) is a medication currently used to treat withdrawal symptoms associated with tobacco use. The purpose of this study is to determine if bupropion will help individuals stop using marijuana.

NCT ID: NCT00137306 Completed - Clinical trials for Substance-Related Disorders

Facilitating the Adoption of Evidence-Based Depression Management in Substance Use Treatment Programs

Start date: January 2004
Phase: Phase 4
Study type: Interventional

Comorbid depression has been consistently linked to worse outcomes for patients in substance abuse treatment programs. Practice guidelines recommend pharmacotherapy for comorbid depression if symptoms persist after a 4-week "wash-out" period for detoxification (e.g., Veterans Health Administration; American Psychiatric Association). Medications may be considered earlier if a patient has current symptoms and a history of major depressive disorder (MDD) during periods of sobriety. Current efficacy data suggest that antidepressant medication can improve both depression and substance use outcomes among comorbid patients Guideline-concordant use of antidepressant medication for persons with comorbid substance use and depressive disorders, however, is not routine in many VA substance abuse treatment settings.

NCT ID: NCT00137267 Completed - Schizophrenia Clinical Trials

A Brief Community Linkage Intervention for Dually Diagnosed Individuals

TLC
Start date: June 2005
Phase: N/A
Study type: Interventional

Surveys suggest that up to 80% of veterans with a persistent mental illness have a co-occurring substance use disorder. Substance abuse among this population is problematic and often results in poor engagement in treatment and thus, frequent hospitalizations and an unstable illness course. Regarding treatment engagement, data from a VA New Jersey facility indicated that 50% of those veterans discharged from the acute psychiatric hospital unit to outpatient care did not attend their initial screening appointment and another 30% dropped out within six weeks. To assist with the transition from inpatient to outpatient care, we previously developed an eight-week augmentation intervention entitled, Time-Limited Case Management (TLC). TLC integrates evidence-based interventions of 1) Dual Recovery Therapy; 2) Critical Time Intervention Case Management along with 3) Peer Support with the goal of assisting individuals with the transition from inpatient to outpatient care.

NCT ID: NCT00135759 Completed - Clinical trials for Substance-Related Disorders

Addition of Naltrexone to Methadone Taper

Start date: April 2005
Phase: Phase 2
Study type: Interventional

There is a continuing search for more effective opiate detoxification treatments. This study's purpose is to investigate the effects of adding very low doses of naltrexone to a methadone tapering treatment in opioid dependent individuals.

NCT ID: NCT00130923 Completed - Schizophrenia Clinical Trials

Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use Disorder

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the efficacy of oral risperidone (Risperdal) to risperidone long-acting (Consta) in reducing alcohol use in persons diagnosed with schizophrenia or schizoaffective disorder.

NCT ID: NCT00118534 Completed - Clinical trials for Tobacco Use Disorder

Integrating Clinical Practice Guidelines for Smoking Cessation Into Mental Health Care for Veterans With Posttraumatic Stress Disorder

Start date: July 2004
Phase: N/A
Study type: Interventional

The primary study objective is to conduct a prospective, randomized controlled clinical trial that compares the effectiveness of two approaches for delivering smoking cessation treatment for veterans with posttraumatic stress disorder (PTSD). An approach where smoking cessation treatment is integrated into mental health care for PTSD and delivered by mental health providers (experimental condition) will be compared to specialized smoking cessation clinic referral (VA's usual standard of care). Secondary study objectives are to (a) compare the cost outcomes and cost-effectiveness of IC versus USC, (b) identify treatment process variables that explain (mediate) observed differences in smoking abstinence rates for the two study conditions, and (c) determine whether cessation from smoking is associated with worsening of symptoms of PTSD and/or depression.

NCT ID: NCT00108407 Completed - Clinical trials for Major Depressive Disorder

Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse

Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether Integrated Cognitive Behavioral Therapy or Twelve Step Facilitation Therapy is most effective for treatment of dually diagnosed veterans with depressive and substance use disorders.

NCT ID: NCT00105729 Completed - Clinical trials for Substance Use Disorders

Substance Abuse Self-Help Group Referral: Outcomes and Services Use

Start date: January 2003
Phase: N/A
Study type: Interventional

Self-help groups (SHGs) have become an important component of the system of care for patients with substance use disorders (SUDs). SUD patients' participation in SHGs has been linked to lower relapse rates and less use of additional treatment services.

NCT ID: NCT00102362 Completed - Clinical trials for Substance-Related Disorders

Job-Seekers Training for Patients With Drug Dependence - 1

Start date: December 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the effectiveness of a 12-hour basic job-training program designed to give drug abuse treatment patients the skills they need to find and secure a job and set vocational goals and methods for locating employment. The intervention to be evaluated is modeled after the Job Seekers' Workshop, which was manualized and has been tested in trials.

NCT ID: NCT00078169 Completed - Clinical trials for Substance-Related Disorders

Motivational Enhancement for Spanish Speaking Individuals - 1

Start date: November 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.